{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} An Introduction to Gender-Affirming Hormone Therapy for Transgender and Gender-Nonbinary Patients

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain gender incongruence and cultural competence.
  2. Describe the informed consent model (ICM) of care.
Price: $12.95

Credits:

  • NBCC 1.0 CH

Wolters Kluwer Health, Inc./Lippincott Continuing Professional Development has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6855. Programs that do not qualify for NBCC credit are clearly identified. Wolters Kluwer Health, Inc./Lippincott Continuing Professional Development is solely responsible for all aspects of the programs.

Test Code: NP0322A-MHC
Published: Mar 2022
Expired: 10/31/2024
Required Passing Score: 8/10 (80%)
Authors: Miles S. Harris, MSN, FNP-BC; B. Ashby Goodrum, MSN, FNP-BC; Chance N. Krempasky, MSN, FNP-BC, WHNP-BC